Next report date
Report period
H2 2023
EPS estimate
—
Revenue estimate
—
−13.27 MUSD
18.42 M
Om OKYO Pharma Limited
Sektor
Bransch
VD
Gary S. Jacob
Webbplats
Huvudkvarter
London
Grundat
2007
ISIN
GG00BMFG5F62
FIGI
BBG015TS35V5
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
